| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA4759043
Max Phase: Preclinical
Molecular Formula: C26H23F3N2O9S2
Molecular Weight: 514.58
Molecule Type: Unknown
Associated Items:
Representations
Canonical SMILES: Cc1ccc(S(=O)(=O)n2cc(-c3ccsc3)c3ccc(CO[C@H](C(=O)O)[C@H](N)C(=O)O)cc32)cc1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C24H22N2O7S2.C2HF3O2/c1-14-2-5-17(6-3-14)35(31,32)26-11-19(16-8-9-34-13-16)18-7-4-15(10-20(18)26)12-33-22(24(29)30)21(25)23(27)28;3-2(4,5)1(6)7/h2-11,13,21-22H,12,25H2,1H3,(H,27,28)(H,29,30);(H,6,7)/t21-,22-;/m0./s1
Standard InChI Key: VMPFGBKJPICYPD-VROPFNGYSA-N
Associated Targets(Human)
SLC1A3 Tchem Excitatory amino acid transporter 1 (586 Activities)
SLC1A2 Tchem Excitatory amino acid transporter 2 (552 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
SLC1A1 Tchem Excitatory amino acid transporter 3 (527 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Associated Targets(non-human)
Slc1a6 Excitatory amino acid transporter 4 (71 Activities)
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 514.58 | Molecular Weight (Monoisotopic): 514.0868 | AlogP: 3.30 | #Rotatable Bonds: 9 |
| Polar Surface Area: 148.92 | Molecular Species: ZWITTERION | HBA: 8 | HBD: 3 |
| #RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 2.63 | CX Basic pKa: 8.97 | CX LogP: 0.90 | CX LogD: -2.29 |
| Aromatic Rings: 4 | Heavy Atoms: 35 | QED Weighted: 0.31 | Np Likeness Score: -0.92 |
References
| 1. Liu N,Jensen AA,Bunch L. (2020) β-Indolyloxy Functionalized Aspartate Analogs as Inhibitors of the Excitatory Amino Acid Transporters (EAATs)., 11 (11): [PMID:33214831] [10.1021/acsmedchemlett.0c00342] |
Source
Source(1):